Miura Toshiyuki, Brockman Mark A, Brumme Zabrina L, Brumme Chanson J, Pereyra Florencia, Trocha Alicja, Block Brian L, Schneidewind Arne, Allen Todd M, Heckerman David, Walker Bruce D
Partners AIDS Research Center, Massachusetts General Hospital, 149 13th St., Room 5212, Charlestown, MA 02129, USA.
J Virol. 2009 Jan;83(1):140-9. doi: 10.1128/JVI.01471-08. Epub 2008 Oct 29.
Human immunodeficiency virus type 1 (HIV-1)-infected persons who maintain plasma viral loads of <50 copies RNA/ml without treatment have been termed elite controllers (EC). Factors contributing to durable control of HIV in EC are unknown, but an HLA-dependent mechanism is suggested by overrepresentation of "protective" class I alleles, such as B27, B51, and B57. Here we investigated the relative replication capacity of viruses (VRC) obtained from EC (n = 54) compared to those from chronic progressors (CP; n = 41) by constructing chimeric viruses using patient-derived gag-protease sequences amplified from plasma HIV RNA and inserted into an NL4-3 backbone. The chimeric viruses generated from EC displayed lower VRC than did viruses from CP (P < 0.0001). HLA-B57 was associated with lower VRC (P = 0.0002) than were other alleles in both EC and CP groups. Chimeric viruses from B57(+) EC (n = 18) demonstrated lower VRC than did viruses from B57(+) CP (n = 8, P = 0.0245). Differences in VRC between EC and CP were also observed for viruses obtained from individuals expressing no described "protective" alleles (P = 0.0065). Intriguingly, two common HLA alleles, A02 and B07, were associated with higher VRC (P = 0.0140 and 0.0097, respectively), and there was no difference in VRC between EC and CP sharing these common HLA alleles. These findings indicate that cytotoxic T-lymphocyte (CTL) selection pressure on gag-protease alters VRC, and HIV-specific CTLs inducing escape mutations with fitness costs in this region may be important for strict viremia control in EC of HIV.
未经治疗而血浆病毒载量维持在<50拷贝RNA/ml的1型人类免疫缺陷病毒(HIV-1)感染者被称为精英控制者(EC)。促成EC对HIV持久控制的因素尚不清楚,但“保护性”I类等位基因如B27、B51和B57的过度表达提示了一种HLA依赖性机制。在此,我们通过构建嵌合病毒来研究从EC(n = 54)获得的病毒(VRC)与慢性进展者(CP;n = 41)的病毒相比的相对复制能力,嵌合病毒使用从血浆HIV RNA扩增并插入NL4-3骨架的患者来源的gag-蛋白酶序列构建。与CP的病毒相比,EC产生的嵌合病毒显示出更低的VRC(P < 0.0001)。在EC组和CP组中,HLA-B57与比其他等位基因更低的VRC相关(P = 0.0002)。来自B57(+) EC(n = 18)的嵌合病毒显示出比来自B57(+) CP(n = 8,P = 0.0245)的病毒更低的VRC。对于从未表达所述“保护性”等位基因的个体获得的病毒,也观察到了EC和CP之间VRC的差异(P = 0.0065)。有趣的是,两个常见的HLA等位基因A02和B07与更高的VRC相关(分别为P = 0.0140和0.0097),并且共享这些常见HLA等位基因的EC和CP之间的VRC没有差异。这些发现表明,细胞毒性T淋巴细胞(CTL)对gag-蛋白酶的选择压力会改变VRC,并且在该区域诱导具有适应性代价的逃逸突变的HIV特异性CTL可能对HIV精英控制者的严格病毒血症控制很重要。